Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Carcinoma, Anaplastic × Histocompatibility Testing × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Breast Neoplasms 6 Pancreatic Neoplasms 4 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymus Neoplasms 1 Thymoma 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Rectal Neoplasms 1 Pancreatitis 1 Pancreatic Diseases 1 Neoplasms, Germ Cell and Embryonal 1 Mesothelioma 1 Medulloblastoma 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Epilepsy 1 Ependymoma 1 Carcinoma, Transitional Cell 1

Interventions

trametinib 9 dabrafenib 9 Paclitaxel 9 pembrolizumab 4 fosbretabulin 4 lenvatinib 3 Sorafenib 3 Radiotherapy, Intensity-Modulated 3 efatutazone 2 combretastatin 2 cobimetinib 2 atezolizumab 2 aldesleukin 2 Vemurafenib 2 Trastuzumab 2 Radiotherapy 2 Gefitinib 2 Filgrastim 2 Everolimus 2 Doxorubicin 2 Docetaxel 2 Cisplatin 2 Carboplatin 2 zimberelimab 1 vandetanib 1 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tremelimumab 1 tislelizumab 1 tipifarnib 1 surufatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01774279 2021-01-05

iNATT

Velindre NHS Trust

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡